Endoscopic sleeve gastroplasty for obese kidney transplant candidates
Official title: Prospective Pilot Study for the Evaluation of Endoscopic Sleeve Gastroplasty With Endomina® for the Treatment of Obesity in Kidney Transplant Candidates
Run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05917795 · Data updated 2026-11-12
This study is testing if a procedure called endoscopic sleeve gastroplasty can help obese patients with kidney disease lose enough weight to qualify for a kidney transplant.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 24 (estimated) |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS Academic / other |
| Locations | 1 site (Rome) |
| Status | Recruiting |
| Started | September 24, 2023 |
| Main results expected | July 1, 2027 |
| Study ends | July 1, 2027 |
| Registry record updated | February 28, 2024 |
| Trial ID | NCT05917795 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 70 with a BMI of 35 kg/m² or higher and chronic kidney disease who are not currently listed for transplantation due to their weight.
✕Probably not a fit
Patients on peritoneal dialysis or those with recent upper gastrointestinal bleeding or active malignancies may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot interventional study evaluates the effectiveness of endoscopic sleeve gastroplasty (ESG) in reducing body mass index (BMI) in obese patients with end-stage renal disease who are candidates for kidney transplantation. The goal is to help participants achieve a BMI below 35 kg/m² within 12 months to qualify for the transplant waiting list. Participants will undergo ESG and will be monitored for weight loss, quality of life, and obesity-related comorbidities for a total of 24 months, including 12 months before and after transplantation.
Why it matters
Potential benefit: If successful, this approach could enable obese kidney transplant candidates to qualify for transplantation by achieving a healthier BMI.
How similar studies have gone: While ESG is a recognized procedure for weight loss, this specific application for kidney transplant candidates is novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients (i.e., age between 18 and 70 years). * BMI ≥ 35 kg/m²; * Patients with chronic kidney disease (CKD) G4-G5 (glomerular filtration rate \[GFR\] \<30ml/min/1.73 m2) who are expected to reach end-stage kidney disease (ESKD) at least 6 to 12 months before anticipated dialysis initiation (pre-emptive transplant candidates) or patients already on haemodialysis when medically stable and kidney failure deemed irreversible; * Patients not listed because of a high BMI according to the policy of the transplant Centre (cut-off 35 kg/m2); * Signed informed consent. Exclusion Criteria: * Patients on peritoneal dialysis * Upper gastro-intestinal bleeding (gastric or oesophageal) in the previous six months; * Ongoing or active malignancy during the last 5 years * Myocardial infarction during the past 6 months or/and heart failure class III or IV according to the New York Heart association's classification; * Previous stomach, oesophagus or duodenum surgery; * Technical non-feasibility in the opinion of the endoscopist; * Clinical signs of active infection; * Concomitant unstoppable anticoagulant or anti platelet therapy, except for low dose aspirin (≤ 100 mg); * Active drugs or alcohol abuse; * Pregnancy, lactation (desire to become pregnant during study duration); * Enrolment in other clinical studies; * Contraindication to general anaesthesia; * Other conditions to exclude the subject in investigators opinion; * Refusal to sign informed consent. -
Where it's running
-
Fondazione Policlinico Universitario A. Gemelli IRCCS
Rome, Italy Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Italian Registry of Pediatric Dialysis: collecting data from kids on kidney replacement therapy
This registry in Italy tests how collecting epidemiological, clinical, and treatment data from children on dialysis or pre-emptive kidney transplants can help centers share protocols and improve care.
-
Glycemic variability after SASI versus Roux-en-Y gastric bypass
This trial tests whether SASI or Roux-en-Y gastric bypass leads to different glucose fluctuations in adults with severe obesity using continuous glucose monitoring.
-
Postoperative nausea, vomiting and pain after bariatric surgery in Sweden
This study looks at how often people have nausea, vomiting, and pain after bariatric surgery in Sweden and whether anesthesia type or regional blocks affect those outcomes.
-
Ribupatide PK in People with Kidney Impairment
This study tests how a single shot of ribupatide behaves in the body for people with severe kidney problems compared to those with normal kidney function.
-
Intraoperative diuretics during deceased-donor kidney transplants
This trial tests whether using furosemide or mannitol during kidney transplant surgery affects delayed graft function in adults receiving a deceased-donor kidney.
-
Intradiay dialysis exercise to improve posture in adults with end-stage kidney disease
This study tests whether a 12-week supervised exercise program done during dialysis can improve posture in adults on maintenance hemodialysis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.